切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Proteasome - sodium channel - NPFF receptor

18件产品中的 1-10

页面
每页
清除全部
  1. VR23
    B6026 VR23
    Target: Proteasome
    Summary: 蛋白酶抑制剂
      ≥45.55 mg/mL
      insoluble in H2O
  2. BIBP 3226 trifluoroacetate
    B7155 BIBP 3226 trifluoroacetate
    Target: NPY Receptors|NPFF receptor
    Summary: 混合NPY Y1和NPFF受体拮抗剂
      ≥78 mg/mL
      ≥12.13 mg/mL
  3. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  4. Lamotrigine
    B2249 Lamotrigine
     1 Citation
    中文名: 拉莫三嗪
    Target: 5-HT receptors|sodium channel
    Summary: 5-HT抑制剂,钠通道阻断剂
      ≥12.3 mg/mL
      insoluble in H2O
  5. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: 泛素活化酶(E1)抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  6. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O
  7. AM 114
    A8163 AM 114
     2 Citation
    Target: Proteasome
    Summary: 20S蛋白酶体抑制剂
      ≥16.65 mg/mL
      insoluble in H2O
  8. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    中文名: 卡非佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥35.99 mg/mL
      insoluble in H2O
  9. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    中文名: 硼替佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥19.21 mg/mL
      insoluble in H2O
  10. MG-115
    A2612 MG-115
     1 Citation
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥23.08 mg/mL
      insoluble in H2O

18件产品中的 1-10

页面
每页